## Abstract The prevalence of antibody to hepatitis C virus (HCV) was studied in 207 patients with chronic liver disease of unknown etiology, in relation to clinical, epidemiological and histological features. Serum antibody to C‐100 epitope of HCV was detected by ELISA in 82.6% of patients, with a
Antibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease
✍ Scribed by Nobukazu Yuki; Norio Hayashi; Akinori Kasahara; Hideki Hagiwara; Keiji Ueda; Hideyuki Fusamoto; Takenobu Kamada
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 574 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To investigate the frequency of exposure to hepatitis C virus (HCV) in chronic liver disease, sera from Japanese patients were tested with the original anti‐HCV assay (Ortho) and an anti‐HCV assay based on synthetic peptides corresponding to a variety of regions in the HCV genome. Thirty‐one (67%) of 46 patients with chronic non‐A, non‐B hepatitis were anti‐HCV‐positive by the Ortho ELISA, 20 of whom were also positive by ELISA based on synthetic HCV peptides. Eight (53%) of the 15 patients negative by the Ortho ELISA tested positive for anti‐HCV by ELISA based on HCV peptides. Serum HCV RNA was detected in all cases positive for antibody to the HCV peptide and in 14 (78%) of 18 cases without antibody. Thirty‐seven hepatitis B virus carriers were without anti‐HCV by the Ortho ELISA and were negative for serum HCV RNA, six (16%) of whom were positive by ELISA based on HCV peptides. Antibody responses were directed against each synthetic HCV peptide used, with a considerable difference in incidence, indicating possible expression of the corresponding region in the course of HCV propagation. These findings indicate that exposure t o HCV may be more common than expected based on the results of the Ortho ELISA. © 1992 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The serological responses to two different hepatitis C virus antigens were studied by enzyme-linked immunosorbent assay in a variety of chronic liver diseases and in healthy blood donors. The study population comprised 97 cases of cryptogenic chronic liver disease (40% with a history suggestive of p
We assessed the correlation between the positivity for serum IgM antibody to hepatitis C virus and the activity of liver disease in patients with chronic hepatitis C virus infection. Serum samples were taken from 10 antibody to hepatitis C virus-positive asymptomatic patients with normal serum ALT l
The recent identification of the hepatitis C virus and development of assays to detect antibodies to hepatitis C virus has allowed assessment of the prevalence of hepatitis C virus infection in patients with a variety of liver and other diseases. The aim of this study was to investigate the prevalen
A total of 146 patients with chronic liver disease, including 20 with chronic hepatitis, 63 with cirrhosis and 62 with primary hepatocellular carcinoma from Nepal were tested for markers of hepatitis B virus or hepatitis C virus infection. HBsAg was detected in 57 (39%) and hepatitis C virus RNA in